Page last updated: 2024-08-23

1-deoxynojirimycin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

1-deoxynojirimycin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Griffin, S; Harris, M; Owsianka, AM; Patel, AH; Rowlands, D; Stgelais, C	1
Block, TM; Dwek, RA; Jordan, R; Mehta, A; Ouzounov, S	1

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

Article	Year
Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:6 Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication	2008
The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral research, 2002, Volume: 55, Issue:3 Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Cattle; Diarrhea Viruses, Bovine Viral; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; In Vitro Techniques; Interferon-alpha; Regression Analysis; Tumor Cells, Cultured; Viral Plaque Assay	2002

Article

Year

Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.

Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:6

Topics: 1-Deoxynojirimycin; Amantadine; Amino Acid Sequence; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Genotype; Hepacivirus; Hepatitis C; Humans; Liver Neoplasms; Molecular Sequence Data; Rimantadine; Viral Proteins; Virus Replication

2008

The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy.

Antiviral research, 2002, Volume: 55, Issue:3

Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Cattle; Diarrhea Viruses, Bovine Viral; Dose-Response Relationship, Drug; Drug Design; Drug Synergism; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Humans; In Vitro Techniques; Interferon-alpha; Regression Analysis; Tumor Cells, Cultured; Viral Plaque Assay

2002